Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Sichuan Zitonggong Pharmaceutical Co Gross Margin %?
Sichuan Zitonggong Pharmaceutical CoBJSE:920566 83 Gross Margin % is 80.00% as of Jun. 2026, which is 2% above its 10-year median of 78.64. GuruFocus rates BJSE:920566 with a GF Score™ of 83/100 and a GF Value™ of ¥10.55 (Fairly Valued). The stock has 1 warning sign investors should review. Among 939 Drug Manufacturers companies, Sichuan Zitonggong Pharmaceutical Co ranks better than 90.42% on this metric.
BJSE:920566's Gross Margin % is ranked better than 90.42% of 939
companies
in the Drug Manufacturers industry
Industry Median: 48.54
vs BJSE:920566: 78.41
Sichuan Zitonggong Pharmaceutical Co had a gross margin of 80.00% for the quarter that ended in Jun. 2026 => Durable competitive advantage
Sichuan Zitonggong Pharmaceutical Co (BJSE:920566) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Sichuan Zitonggong Pharmaceutical Co had a gross margin of 80.00% for the quarter that ended in Jun. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Sichuan Zitonggong Pharmaceutical Co Gross Margin % Related Terms
Sichuan Zitonggong Pharmaceutical Co Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sichuan Zitonggong Pharmaceutical Co Gross Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Sichuan Zitonggong Pharmaceutical Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sichuan Zitonggong Pharmaceutical Co Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sichuan Zitonggong Pharmaceutical Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Sichuan Zitonggong Pharmaceutical Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Sichuan Zitonggong Pharmaceutical Co (BJSE:920566) has a Gross Margin % of 80.00% as of Jun. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Sichuan Zitonggong Pharmaceutical Co and its competitors. This is near median its historical median of 78.64. Over the past decade, Sichuan Zitonggong Pharmaceutical Co's Gross Margin % has ranged from 74.02 to 80.94. According to the industry distribution chart, Sichuan Zitonggong Pharmaceutical Co ranks #90 out of 939 companies in the Drug Manufacturers industry, placing it in the top 9.6%.
Is Sichuan Zitonggong Pharmaceutical Co's Gross Margin % too high?
Sichuan Zitonggong Pharmaceutical Co's current Gross Margin % of 80.00% is near median its 10-year median of 78.64. Over the past 10 years, this metric has ranged from a low of 74.02 to a high of 80.94. The Drug Manufacturers industry median Gross Margin % is 48.54. Sichuan Zitonggong Pharmaceutical Co's value of 80.00% is 64.8% above this industry median. Based on the distribution chart, Sichuan Zitonggong Pharmaceutical Co ranks #90 out of 939 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Sichuan Zitonggong Pharmaceutical Co has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sichuan Zitonggong Pharmaceutical Co's Gross Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Sichuan Zitonggong Pharmaceutical Co ranks #90 out of 939 companies for Gross Margin %. This places Sichuan Zitonggong Pharmaceutical Co in the top 10% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 48.54. Sichuan Zitonggong Pharmaceutical Co's value of 80.00% is 64.8% above this benchmark. Historically, Sichuan Zitonggong Pharmaceutical Co's own Gross Margin % has ranged from 74.02 to 80.94 over the past decade. While the company's 10-year median is 78.64 vs. the industry median of 48.54, Sichuan Zitonggong Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 939 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sichuan Zitonggong Pharmaceutical Co's current Gross Margin % of 80.00% is 64.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Sichuan Zitonggong Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sichuan Zitonggong Pharmaceutical Co's current Gross Margin % is 80.00%, which is near median its own 10-year median of 78.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sichuan Zitonggong Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Sichuan Zitonggong Pharmaceutical Co (BJSE:920566) is currently considered Fairly Valued. The stock's GF Value™ is ¥10.55, compared to a current price of ¥9.71 — trading 8% below its estimated fair value. The current Gross Margin % is 80.00%, which is near median its 10-year median of 78.64 and 64.8% above the Drug Manufacturers industry median of 48.54. Sichuan Zitonggong Pharmaceutical Co's overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Sichuan Zitonggong Pharmaceutical Co (BJSE:920566), the current Gross Margin % is 80.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sichuan Zitonggong Pharmaceutical Co (BJSE:920566) Overvalued in 2026?
Based on GuruFocus' analysis, Sichuan Zitonggong Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥9.71 is trading 8% below its estimated GF Value™ of ¥10.55.
GuruFocus considers Sichuan Zitonggong Pharmaceutical Co to be Fairly Valued.
Key valuation signals for BJSE:920566:
Gross Margin %: 80.00% (near median its 10-year median of 78.64)
GF Value™: ¥10.55 vs. price of ¥9.71 (8% below fair value)
Industry Position: 64.8% above the Drug Manufacturers median (#90 of 939)
No single metric tells the full story. See the BJSE:920566 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sichuan Zitonggong Pharmaceutical Co Ltd is a high-tech enterprise focusing on the R&D, production, and marketing of tablets, hard capsules, liniments, powders, and ointments. It has developed a number of drug varieties, such as Citicoline Sodium Tablets and Rizatriptan Benzoate Capsules.
83GF Score
Get the complete analysis for BJSE:920566
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920566 has been successfully added to your 
